Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
地塞米松用于治疗复发/难治性多发性骨髓瘤患者接受teclistamab治疗后出现的细胞因子释放综合征(CRS)。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01222-y
Davis, James A; Snyder, Jordan; Rice, Mikhaila; Moore, Donald C; Cahoon, Christopher; Julian, Kelley; Wagner, Charlotte B; Granger, Katelynn; Green, Kimberly M; Atrash, Shebli; Hill, Hailey; McElwee, Jessica; Elsey, Grace; Khouri, Jack; Rudoni, Joslyn; Mahmoudjafari, Zahra; Nachar, Victoria R